2001
MR Renography with Low-Dose Gadopentetate Dimeglumine: Feasibility
Lee V, Rusinek H, Johnson G, Rofsky N, Krinsky G, Weinreb J. MR Renography with Low-Dose Gadopentetate Dimeglumine: Feasibility. Radiology 2001, 221: 371-9. PMID: 11687678, DOI: 10.1148/radiol.2212010142.Peer-Reviewed Original ResearchMeSH KeywordsAngiotensin-Converting Enzyme InhibitorsContrast MediaFeasibility StudiesFemaleGadolinium DTPAHumansMagnetic Resonance ImagingMaleMiddle AgedRadioisotope RenographyRenal Artery ObstructionConceptsRenal artery stenosisACE inhibitorsCreatinine levelsIntravenous injectionMedullary enhancementMR renographyAngiotensin converting enzyme (ACE) inhibitorsGadopentetate dimeglumineMR angiographyContrast material-enhanced MR angiographyElevated creatinine levelSerum creatinine levelsMaterial-enhanced MR angiographyConverting Enzyme InhibitorsGadolinium-enhanced MR angiographyRenographic findingsRenovascular diseaseRenal functionArtery stenosisRenal cortexPatientsEnzyme inhibitorsContrast materialClinical settingRenography
2000
Angiotensin-converting enzyme inhibitor-enhanced phase-contrast MR imaging to measure renal artery velocity waveforms in patients with suspected renovascular hypertension.
Lee V, Rofsky N, Ton A, Johnson G, Krinsky G, Weinreb J. Angiotensin-converting enzyme inhibitor-enhanced phase-contrast MR imaging to measure renal artery velocity waveforms in patients with suspected renovascular hypertension. American Journal Of Roentgenology 2000, 174: 499-508. PMID: 10658731, DOI: 10.2214/ajr.174.2.1740499.Peer-Reviewed Original Research